Psychopharmacology and Psychiatry Updates cover image

Lurasidone's Therapeutic Window: Is Less More?

Psychopharmacology and Psychiatry Updates

00:00

Risk-Benefit at 40–60 mg

Kristin explains reduced akathisia/parkinsonism risk and a trend to protect against hypomania at 50–60 mg.

Play episode from 06:36
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app